title: Hemostatic Factors, APOL1, and ESRD Risk: Another Piece of the Puzzle?
authors.affiliation: Division of Nephrology, Mayanei HaYeshua Medical Center, Bnei Brak, Israel; and Division of Nephrology, Rambam Health Care Campus, Haifa, Israel Lcdialysis@aol.com.
authors.forename: Walter G
authors.initials: WG
authors.lastname: Wasser
authors.affiliation: Division of Nephrology, Rambam Health Care Campus, Haifa, Israel.
authors.forename: Etty
authors.initials: E
authors.lastname: Kruzel-Davila
mesh_terms: D001741:Black or African American / Q000235:genetics*; D001053:Apolipoproteins / Q000235:genetics*; D001779:Blood Coagulation Factors / Q000378:metabolism*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology*; D008075:Lipoproteins, HDL / Q000235:genetics*; D008297:Male; D044465:White People / Q000235:genetics*
chemical_list: D001053:Apolipoproteins; D001779:Blood Coagulation Factors; D008075:Lipoproteins, HDL
keywords: CKD; FSGS; HIV nephropathy; endothelium